Earnings Call for Q4FY22 of Natco Pharma

Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

855.9500 14.80 (1.76%)

NSE May 05, 2025 15:31 PM

47.78% Fall from 52W High

Volume: 452.7K

Conference/Earnings Calls Alerts

Natco Pharma Ltd.

31 May 2022

855.95

1.76%

Earnings Call for Q4FY22 of Natco Pharma

Conference Call with Natco Pharma Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.

More from Natco Pharma Ltd.

All Rapid Results

Recommended

IPOs This Week: Ather Energy and Four Other Listings, Plus New Public Issues

| 05 May 2025, 04:52PM

Market closes higher, Netweb Tech's Q4FY25 net profit grows 41.8% QoQ to Rs 43 crore

Trendlyne Marketwatch | 05 May 2025, 04:01PM

Earnings Call Transcript - Q4FY20 for Natco Pharma